[1]JournaloftheChemicalSociety,1956,p.917,920
[1]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.5247-5250
[2]EuropeanJournalofMedicinalChemistry,2008,vol.43,p.1248-1260
Title: Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.
Journal: Journal of medicinal chemistry 20120322
Title: The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism.
Journal: Bioorganic & medicinal chemistry letters 20100301
Title: Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule 'crystallization chaperone' 5'-O-tritylinosine (KIN59).
Journal: Biochemical pharmacology 20090801
Title: Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures.
Journal: Circulation research 20090102
Title: Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors.
Journal: European journal of medicinal chemistry 20080601
Title: Aminoimidazolylmethyluracil analogues as potent inhibitors of thymidine phosphorylase and their bioreductive nitroimidazolyl prodrugs.
Journal: Journal of medicinal chemistry 20050127
Title: Synthesis and enzymatic evaluation of xanthine oxidase-activated prodrugs based on inhibitors of thymidine phosphorylase.
Journal: Bioorganic & medicinal chemistry letters 20041101
Title: Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening.
Journal: Bioorganic & medicinal chemistry letters 20031103
Title: Potential tumor-selective nitroimidazolylmethyluracil prodrug derivatives: inhibitors of the angiogenic enzyme thymidine phosphorylase.
Journal: Journal of medicinal chemistry 20030116